Concepedia

David Gardiner

DG

33

Publications

3.6K

Citations

22

H-Index

1977

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

University of Colorado Denver

Aaron Diamond AIDS Research Center

Rockefeller University

GlaxoSmithKline (United States)

David Gardiner is an author at Bristol-Myers Squibb (United States) specializing in medicine, virology, and hepatitis.

Top concepts

Publications per year

1977–2021

33

Publications

33

Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection

Mark Sulkowski, David Gardiner, M. Rodríguez‐Torres et al. · New England Journal of Medicine · 2014 · 1.2K citations

Preliminary Study of Two Antiviral Agents for Hepatitis C Genotype 1

Anna S. Lok, David Gardiner, Eric Lawitz et al. · New England Journal of Medicine · 2012 · 607 citations · Full text

A Randomized, Double-Blind, Placebo-Controlled Assessment of BMS-936558, a Fully Human Monoclonal Antibody to Programmed Death-1 (PD-1), in Patients with Chronic Hepatitis C Virus Infection

David Gardiner, Jay Lalezari, Eric Lawitz et al. · PLoS ONE · 2013 · 227 citations · Full text

Efficacy of an Interferon- and Ribavirin-Free Regimen of Daclatasvir, Asunaprevir, and BMS-791325 in Treatment-Naive Patients With HCV Genotype 1 Infection

Gregory T. Everson, Karen Sims, M. Rodríguez‐Torres et al. · Gastroenterology · 2013 · 198 citations · Full text

In Vivo Electroporation Enhances the Immunogenicity of an HIV-1 DNA Vaccine Candidate in Healthy Volunteers

Sandhya Vasan, Arlene Hurley, Sarah J. Schlesinger et al. · PLoS ONE · 2011 · 184 citations · Full text

Rows per page

1–5 of 33